SAN FRANCISCO, CA—Srikanth Vallurupalli, MD, and colleagues from the University of Arkansas Medical Sciences, Little Rock, AR presented results at ACC.13, the American College of Cardiology’s 62 nd ...

Patients with cancer who received prophylactic intravenous (IV) magnesium before starting cisplatin had a lower risk for cisplatin-associated acute kidney injury (AKI) than those who did not receive ...

The probability of spontaneous conversion to sinus rhythm (SVC) was increased with the intravenous administration of magnesium and potassium in patients with nonpermanent atrial fibrillation ...

Shruti Gupta, MD, MPH, and David Leaf, MD, MMSc, of the Renal Division, Department of Medicine at Brigham and Women's Hospital are the first and senior authors, respectively, of a paper published in ...

Nearly 9 in 10 children given intravenous (IV) magnesium for refractory asthma ended up being admitted to the hospital, but new research suggests that may be partly due to a lack of clarity about the ...

SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- The global magnesium supplement market continues to grow (estimated at a 7–8% CAGR) as more consumers become concerned about magnesium deficiency, ...

In the first study of its kind, a consortium led by UCLA physicians found that giving stroke patients intravenous magnesium within an hour of symptom onset does not improve stroke outcomes, according ...

Please provide your email address to receive an email when new articles are posted on . IV magnesium therapy administered after initial asthma treatment in the ED was associated with subsequent ...

In the first study of its kind, a consortium of physicians found that giving stroke patients intravenous magnesium within an hour of symptom onset does not improve stroke outcomes, according to ...

Patients with cancer who received IV magnesium on the day of cisplatin administration had significant 27% lower odds of cisplatin-associated AKI compared with those who did not receive IV magnesium.

electrolyte test The first systematic review of epidermal growth factor receptor (EGFR) inhibitor induced hypomagnesemia has concluded no optimal magnesium supplement strategy currently exists to ...

Confirmation of deficient mismatch repair (dMMR) as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer (CC): A pooled molecular reanalysis of ...